VNS Therapy™ for Epilepsy

VNS Therapy™ is a medical device proven to treat difficult-to-control seizures, also known as drug-resistant epilepsy. The device sends mild pulses through the vagus nerve to areas of the brain known to be associated with seizures. More than 125,000 people worldwide have received VNS Therapy as a treatment for drug-resistant epilepsy, including over 30,000 children. INTENDED USE/INDICATIONS-UNITED STATES VNS Therapy is indicated for use as an adjunctive therapy in reducing the frequency of seizures in people over 4 years of age with partial onset seizures that are refractory to antiepileptic medications. ADVERSE EVENTS The most commonly reported side effects from stimulation include hoarseness (voice alteration), paresthesia (prickling feeling in the skin), dyspnea (shortness of breath), sore throat and increased coughing. Other adverse events reported during clinical studies as statistically significant are ataxia (loss of the ability to coordinate muscular movement); dyspepsia (indigestion); hypesthesia (impaired sense of touch); insomnia (inability to sleep); laryngismus (throat, larynx spasms); nausea; pain; pharyngitis (inflammation of the pharynx, throat); and vomiting. These typically occur only during stimulation, are well tolerated and noticed less as time goes on. The most commonly reported side effect from the implant procedure is infection. PAGE POLICIES LivaNova is monitoring page activity, and reserves the right to delete any messages. For example, off topic, derogatory or spam messages may be grounds for deletion. A company representative may follow up on complaints reported on this page. For more information about VNS Therapy, its indications, contraindications, warnings and precautions, visit VNSTherapy.com or contact your healthcare provider. For LivaNova career and company information, please visit http://bit.ly/2qTNB5y.